The extended participation of the Review Choice Demonstration (RCD) for Home Health Agencies in Florida and North Carolina is ending on March 31, 2021. Home health agencies in these states will now be required to process their claims under their selected review option. If your agency has chosen the Pre-Claim Review, here are some…
With the Patient-Driven Grouping Model (PDGM) ruling out therapy volume as a driving factor for reimbursements, home health agencies are challenged to explore ways to optimize utilization and revenue base. The new Medicare Home Infusion Therapy (HIT) benefit, which took effect on January 1st, 2021, holds the potential for home health agencies to offer…
A recent survey covering the home health industry reveals the greatest challenges in the year ahead, areas of expense specifically related to the COVID-19 pandemic, technology adoption, and areas of growth and efficiency, among other findings. Key takeaway Staffing remains the single most challenging aspect of home health. It’s been a top concern for…
The new no-pay Request for Anticipated Payment (RAP) requirement is perhaps the most notable change home health agencies have had to prepare for in compliance with the CY2021 Home Health Final Rule, which took effect January 1st. As agencies are getting into the rhythm of the new timeline for no-pay RAPs, more questions and challenges…